| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. | V Uchaipichat PI Mackenzie XH Guo D Gardner-Stephen A Galetin JB Houston JO Miners |
2004 | ||||
| 2. | Erratum: Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid (Drug Metabolism Disposition (2004) 32 (413-423)) | Uchaipichat, V. | 2005 | ||||
| 3. | Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid (vol 32, pg 413, 2004) | V Uchaipichat PI Mackenzie XH Guo D Gardner-Stephen A Galetin JB Houston JO Miners |
2005 | ||||
| 4. | Characterisation of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates using multisite kinetic modelling | Verawan Uchaipichat Peter Mackenzie Brian Houston Aleksandra Galetin John Miners |
2006 | ||||
| 5. | Multisite kinetic modelling of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates | Aleksandra Galetin Verawan Uchaipichat Peter I. Mackenzie J. Brian Houston John O. Miners |
2006 | ||||
| 6. | Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation. | V Uchaipichat LK Winner PI Mackenzie DJ Elliot JA Williams JO Miners |
2006 | ||||
| 7. | Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir | Srasuebkul, P. Ruxrungtham, K. Uchaipichat, V. Phanuphak, P.P. Cooper, D.A. Udomuksorn, W. |
2006 | ||||
| 8. | Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases. | Uchaipichat, V. | 2006 | ||||
| 9. | UNRAVELLING THE KINETIC ANOMALIES OF UDP-GLUCURONOSYLTRANSFERASES | John O. Miners Andrew Rowland Verawan Uchaipichat David J. Elliot Kathleen M. Knights Peter I. Mackenzie |
2007 | ||||
| 10. | Adverse Drug Reaction Monitoring to Antiepileptic Drugs by Patient Self Reports | Piyanida Senacom Narumol Jarernsiripornkul Verawan Uchaipichat |
2008 | ||||
| 11. | Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by UDP-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites | Verawan Uchaipichat Aleksandra Galetin J. Brian Houston Peter I. Mackenzie J. Andrew Williams John O. Miners |
2008 | ||||
| 12. | The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring. | Uchaipichat, V. Koanantakul, B. |
2008 | ||||
| 13. | Albumin Effect on In Vitro Codeine (COD) Glucuronidation: Improving the Prediction of Hepatic Intrinsic Clearance | Pritsana Raungrut Benjamas Janchawee Verawan Uchaipichat David J. Elliot John O. Miners |
2009 | ||||
| 14. | Development of a High Performance Liquid Chromatography with Coulometric Electrochemical Detector Method for the Analysis of Morphine in Human Plasma | Thanee Tessiri Viroj Sumyai Suvatana Chulavatnatol Poj Kulvanich Khanittha Tontisirin Thaned Pongjanyakul Sirikul Aumpon Verawan Uchaipichat Detpon Preechagoon |
2009 | ||||
| 15. | Inhibition of codeine glucuronidation in vitro by fluconazole, ketamine, ketoconazole and valproic acid: Prediction of in vivo drug-drug interaction potential | John O. Miners Pritsana Raungrut Verawan Uchaipichat David J. Elliot Benjamas Janchawee |
2009 | ||||
| 16. | Effect of Albumin on Human Cytochromes P450 Kinetics: Extrapolation of in Vivo Clearance from in Vitro Data | Nitsupa Wattanachai David J. Elliot Verawan Uchaipichat Wichittra Tassaneeyakul John O. Miners |
2010 | ||||
| 17. | Effects of Andrographispaniculata and Orthosiphon stamineus extracts on the glucuronidation of 4-methylumbelliferone in human UGT isoforms | Sabariah Ismail Nur Aziah Hanapi Mohd Rohaimi Ab Halim Verawan Uchaipichat Peter I. Mackenzie |
2010 | ||||
| 18. | Formulation development of morphine sulfate sustained-release tablets and its bioequivalence study in healthy Thai volunteers. | Detpon Preechagoon Viroj Sumyai Suvatna Chulavatnatol Poj Kulvanich Thanee Tessiri Khanittha Tontisirin Thaned Pongjanyakul Verawan Uchaipichat Sirikul Aumpon Chaiyasit Wongvipaporn |
2010 | ||||
| 19. | In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans. | Pritsana Raungrut Verawan Uchaipichat David J. Elliot Benjamas Janchawee Andrew A. Somogyi John O. Miners |
2010 | ||||
| 20. | Kinetic and Enzymatic Characterisation of Human Hepatic R- and S- Lorazepam Glucuronidation | Verawan Uchaipichat Chuthamanee Suthisisang Peter I. Mackenzie John O. Miners |
2010 | ||||
| 21. | The Albumin Effect on In vitro Kinetics of Various Cytochrome P450-Catalyzed Reactions: In vitro to In vivo Extrapolation | Nitsupa Wattanachai Wichittra Tassaneeyakul Verawan Uchaipichat John O. Miners |
2010 | ||||
| 22. | Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation | Uchaipichat, V Raungrut, P Chau, N Janchawee, B Evans, AM Miners, JO |
2011 | ||||
| 23. | In vitro approaches for the prediction of inhibition of drug glucuronidation clearance in humans | Verawan Uchaipichat Peter I. Mackenzie John O. Miners |
2011 | ||||
| 24. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance. | Nitsupa Wattanachai Thomas M. Polasek Tahlia M. Heath Verawan Uchaipichat Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul John O. Miners |
2011 | ||||
| 25. | In vitro - in vivo extrapolation predicts a potential metabolic drug-drug interaction between ketamine and morphine | Verawan Uchaipichat Nuy Chau Pritsana Raungrut Benjamas Janchawee Peter Mackenzie John Miners |
2011 | ||||
| 26. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy | Jarernsiripornkul, N. Senacom, P. Uchaipichat, V. Chaipichit, N. Krska, J. |
2012 | ||||
| 27. | The glucuronidation of R- and S-lorazepam: human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugs. | Uchaipichat, V. | 2013 | ||||
| 28. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions | Chaipichit, N Krska, J Pratipanawatr, T Uchaipichat, V Jarernsiripornkul, N |
2014 | ||||
| 29. | Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2014 | ||||
| 30. | Experiences of adverse drug effects reported by patients in ambulatory clinic | Narumol Jarernsiripornkul Nataporn Chaipichit Janet Krska Verawan Uchaipichat Thongchai Pratipanawatr |
2015 | ||||
| 31. | Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2015 | ||||
| 32. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions. | Narumol Jarernsiripornkul Nataporn Chaipichit Thongchai Pratipanawatr Verawan Uchaipichat Janet Krska |
2016 | ||||
| 33. | Prevalence of Potential Statin-Drug Interactions in Dyslipidemic Patients at Srinagarind Hospital | Jantira Roddech Panadchanun Phiwbang Panjittra Kitirach Patcharin Nisanggad Pansu Sriangkan Chaiyasith Wongvipaporn Verawan Uchaipichat |
2016 | ||||
| 34. | Warfarin using knowledge and international normalized ratio goal control in outpatients of Queen Sirikit heart center of the northeast | Pattavee Loharattanakong Ploypilin Ritthiboon Yuwatida Hongrinya Maneepimai Chaichun Suthep Taksinachanekij Verawan Uchaipichat |
2016 | ||||
| 35. | Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction | Uchaipichat, V. | 2017 | ||||
| 36. | In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans | Uchaipichat, V. | 2018 | ||||
| 37. | In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans. | Uchaipichat, V | 2018 | ||||
| 38. | IN VITRO INHIBITORY EFFECT OF TRICYCLIC ANTIDEPRESSANTS ON HUMAN LIVER MICROSOMAL MORPHINE GLUCURONIDATION | Verawan Uchaipichat Nantawat Thothumpol Nattaya Janpae |
2020 | ||||
| 39. | Inhibitory effects of non-steroidal anti-inflammatory drugs on human liver microsomal morphine glucuronidation: Implications for drug-drug interaction liability | Uchaipichat, V Rowland, A Miners, JO |
2022 | ||||
| 40. | Inhibitory effects of Kratom constituents, mitragynine and 7-hydroxymitragynine, on 4-methylumbelliferone glucuronidation by human UDP-glucuronosyltransferases. | Uchaipichat, V. | 2025 | Count | 20 | 19 | 29 | 6 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid | Uchaipichat, V. | 2004 |
Drug Metabolism and Disposition 4 (32), pp. 413-423 |
||||||||
| 2. | Erratum: Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid (Drug Metabolism Disposition (2004) 32 (413-423)) | Uchaipichat, V. | 2005 |
Drug Metabolism and Disposition 12 (33), pp. 1925-1926 |
||||||||
| 3. | Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: The effect of fluconazole on zidovudine glucuronidation | Uchaipichat, V. Winner, L.K. |
2006 |
British Journal of Clinical Pharmacology 4 (61), pp. 427-439 |
||||||||
| 4. | Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir | Srasuebkul, P. Ruxrungtham, K. Uchaipichat, V. Phanuphak, P.P. Cooper, D.A. Udomuksorn, W. |
2006 |
Pharmacogenetics and Genomics 5 (16), pp. 321-329 |
||||||||
| 5. | Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human UDP-glucuronosyltransferases | Uchaipichat, V. | 2006 |
Drug Metabolism and Disposition 3 (34), pp. 449-456 |
||||||||
| 6. | Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by UDP-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites | Uchaipichat, V. | 2008 |
Molecular Pharmacology 4 (74), pp. 1152-1162 |
||||||||
| 7. | The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring | Uchaipichat, V. Koanantakul, B. |
2008 |
Journal of the Medical Association of Thailand 9 (91), pp. 1468-1477 |
||||||||
| 8. | Effects of Andrographispaniculata and Orthosiphon stamineus extracts on the glucuronidation of 4-methylumbelliferone in human UGT isoforms | Hanapi, N.A. Ab Halim, M.R. Uchaipichat, V. |
2010 |
Molecules 5 (15), pp. 3578-3592 |
||||||||
| 9. | Formulation development of morphine sulfate sustained-release tablets and its bioequivalence study in healthy thai volunteers | Preechagoon, D. Tessiri, T. Pongjanyakul, T. Uchaipichat, V. Wongvipaporn, C. |
2010 |
AAPS PharmSciTech 3 (11), pp. 1449-1455 |
||||||||
| 10. | In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans | Uchaipichat, V. Janchawee, B. |
2010 |
Journal of Pharmacology and Experimental Therapeutics 2 (334), pp. 609-618 |
||||||||
| 11. | Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation | Uchaipichat, V. Janchawee, B. |
2011 |
Drug Metabolism and Disposition 8 (39), pp. 1324-1328 |
||||||||
| 12. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance | Wattanachai, N. Uchaipichat, V. Tassaneeyakul, W. Tassaneeyakul, W. |
2011 |
European Journal of Clinical Pharmacology 8 (67), pp. 815-824 |
||||||||
| 13. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy | Jarernsiripornkul, N. Senacom, P. Uchaipichat, V. Chaipichit, N. Krska, J. |
2012 |
Epilepsy and Behavior 1 (24), pp. 102-106 |
||||||||
| 14. | The glucuronidation of R- and S-lorazepam: Human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugs | Uchaipichat, V. | 2013 |
Drug Metabolism and Disposition 6 (41), pp. 1273-1284 |
||||||||
| 15. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions | Chaipichit, N. Krska, J. Pratipanawatr, T. Uchaipichat, V. Jarernsiripornkul, N. |
2014 |
European Journal of Clinical Pharmacology 5 (70), pp. 607-615 |
||||||||
| 16. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions | Jarernsiripornkul, N. Chaipichit, N. Pratipanawatr, T. Uchaipichat, V. Krska, J. |
2016 |
Pharmacoepidemiology and Drug Safety 1 (25), pp. 54-63 |
||||||||
| 17. | Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction | Uchaipichat, V. | 2017 |
Saudi Pharmaceutical Journal 6 (25), pp. 823-829 |
||||||||
| 18. | In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans | Uchaipichat, V. | 2018 |
Drug Metabolism and Pharmacokinetics 1 (33), pp. 67-76 |
||||||||
| 19. | Inhibitory effects of non-steroidal anti-inflammatory drugs on human liver microsomal morphine glucuronidation: Implications for drug-drug interaction liability | Uchaipichat, V. | 2022 |
Drug Metabolism and Pharmacokinetics (42), pp. |
||||||||
| 20. | Inhibitory effects of Kratom constituents, mitragynine and 7-hydroxymitragynine, on 4-methylumbelliferone glucuronidation by human UDP-glucuronosyltransferases | Uchaipichat, V. | 2025 |
Toxicology Reports (14), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. | Uchaipichat, V Mackenzie, PI Guo, XH Gardner-Stephen, D Galetin, A Houston, JB Miners, JO |
2004 |
Drug metabolism and disposition: the biological fate of chemicals 4 (32), pp. 413-23 |
|
| 2. | Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation. | Uchaipichat, V Winner, LK Mackenzie, PI Elliot, DJ Williams, JA Miners, JO |
2006 |
British journal of clinical pharmacology 4 (61), pp. 427-39 |
|
| 3. | Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir. | Boyd, MA Srasuebkul, P Ruxrungtham, K Mackenzie, PI Uchaipichat, V Stek, M Lange, JM Phanuphak, P Cooper, DA Udomuksorn, W Miners, JO |
2006 |
Pharmacogenetics and genomics 5 (16), pp. 321-9 |
|
| 4. | Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases. | Uchaipichat, V Mackenzie, PI Elliot, DJ Miners, JO |
2006 |
Drug metabolism and disposition: the biological fate of chemicals 3 (34), pp. 449-56 |
|
| 5. | Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites. | Uchaipichat, V Galetin, A Houston, JB Mackenzie, PI Williams, JA Miners, JO |
2008 |
Molecular pharmacology 4 (74), pp. 1152-62 |
|
| 6. | The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring. | Uchaipichat, V Koanantakul, B Suthisisang, C |
2008 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 9 (91), pp. 1468-77 |
|
| 7. | Formulation development of morphine sulfate sustained-release tablets and its bioequivalence study in healthy Thai volunteers. | Preechagoon, D Sumyai, V Chulavatnatol, S Kulvanich, P Tessiri, T Tontisirin, K Pongjanyakul, T Uchaipichat, V Aumpon, S Wongvipaporn, C |
2010 |
AAPS PharmSciTech 3 (11), pp. 1449-55 |
|
| 8. | Effects of Andrographis paniculata and Orthosiphon stamineus extracts on the glucuronidation of 4-methylumbelliferone in human UGT isoforms. | Ismail, S Hanapi, NA Ab Halim, MR Uchaipichat, V Mackenzie, PI |
2010 |
Molecules (Basel, Switzerland) 5 (15), pp. 3578-92 |
|
| 9. | In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans. | Raungrut, P Uchaipichat, V Elliot, DJ Janchawee, B Somogyi, AA Miners, JO |
2010 |
The Journal of pharmacology and experimental therapeutics 2 (334), pp. 609-18 |
|
| 10. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance. | Wattanachai, N Polasek, TM Heath, TM Uchaipichat, V Tassaneeyakul, W Tassaneeyakul, W Miners, JO |
2011 |
European journal of clinical pharmacology 8 (67), pp. 815-24 |
|
| 11. | Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation. | Uchaipichat, V Raungrut, P Chau, N Janchawee, B Evans, AM Miners, JO |
2011 |
Drug metabolism and disposition: the biological fate of chemicals 8 (39), pp. 1324-8 |
|
| 12. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. | Jarernsiripornkul, N Senacom, P Uchaipichat, V Chaipichit, N Krska, J |
2012 |
Epilepsy & behavior : E&B 1 (24), pp. 102-6 |
|
| 13. | The glucuronidation of R- and S-lorazepam: human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugs. | Uchaipichat, V Suthisisang, C Miners, JO |
2013 |
Drug metabolism and disposition: the biological fate of chemicals 6 (41), pp. 1273-84 |
|
| 14. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. | Chaipichit, N Krska, J Pratipanawatr, T Uchaipichat, V Jarernsiripornkul, N |
2014 |
European journal of clinical pharmacology 5 (70), pp. 607-15 |
|
| 15. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions. | Jarernsiripornkul, N Chaipichit, N Pratipanawatr, T Uchaipichat, V Krska, J |
2016 |
Pharmacoepidemiology and drug safety 1 (25), pp. 54-63 |
|
| 16. | Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction. | Siriangkhawut, M Tansakul, P Uchaipichat, V |
2017 |
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 6 (25), pp. 823-829 |
|
| 17. | In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans. | Uchaipichat, V | 2018 |
Drug metabolism and pharmacokinetics 1 (33), pp. 67-76 |
|
| 18. | Inhibitory effects of non-steroidal anti-inflammatory drugs on human liver microsomal morphine glucuronidation: Implications for drug-drug interaction liability. | Uchaipichat, V Rowland, A Miners, JO |
2022 |
Drug metabolism and pharmacokinetics (42), pp. 100442 |
|
| 19. | Inhibitory effects of Kratom constituents, mitragynine and 7-hydroxymitragynine, on 4-methylumbelliferone glucuronidation by human UDP-glucuronosyltransferases. | Uchaipichat, V | 2025 |
Toxicology reports (14), pp. 101951 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid | V Uchaipichat PI Mackenzie XH Guo D Gardner-Stephen A Galetin JB Houston JO Miners |
2004 |
DRUG METABOLISM AND DISPOSITION 4.0 (32.0), pp. 413.0-423.0 |
226 | 0 | 0 | 0 | 0 | 0 | 226 | |
| 2. | Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid (vol 32, pg 413, 2004) | V Uchaipichat PI Mackenzie XH Guo D Gardner-Stephen A Galetin JB Houston JO Miners |
2005 |
DRUG METABOLISM AND DISPOSITION 12.0 (33.0), pp. 1925.0-1926.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 3. | Characterisation of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates using multisite kinetic modelling | Verawan Uchaipichat Peter Mackenzie Brian Houston Aleksandra Galetin John Miners |
2006 |
ACTA PHARMACOLOGICA SINICA (27.0), pp. 218.0-218.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 4. | Multisite kinetic modelling of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates | Aleksandra Galetin Verawan Uchaipichat Peter I. Mackenzie J. Brian Houston John O. Miners |
2006 |
DRUG METABOLISM REVIEWS (38.0), pp. 45.0-46.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation | V Uchaipichat LK Winner PI Mackenzie DJ Elliot JA Williams JO Miners |
2006 |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 4.0 (61.0), pp. 427.0-439.0 |
119 | 0 | 0 | 0 | 0 | 0 | 119 | |
| 6. | Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir | MA Boyd P Srasuebkul K Ruxrungtham PI Mackenzie V Uchaipichat M Stek JMA Lange P Phanuphak DA Cooper W Udomuksorn JO Miners |
2006 |
PHARMACOGENETICS AND GENOMICS 5.0 (16.0), pp. 321.0-329.0 |
33 | 0 | 0 | 0 | 0 | 0 | 33 | |
| 7. | Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) probes for human UDP- glucuronosyltransferases | V Uchaipichat PI Mackenzie DJ Elliot JO Miners |
2006 |
DRUG METABOLISM AND DISPOSITION 3.0 (34.0), pp. 449.0-456.0 |
161 | 0 | 0 | 0 | 0 | 0 | 161 | |
| 8. | UNRAVELLING THE KINETIC ANOMALIES OF UDP-GLUCURONOSYLTRANSFERASES | John O. Miners Andrew Rowland Verawan Uchaipichat David J. Elliot Kathleen M. Knights Peter I. Mackenzie |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 11.0-11.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 9. | Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by UDP-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites | Verawan Uchaipichat Aleksandra Galetin J. Brian Houston Peter I. Mackenzie J. Andrew Williams John O. Miners |
2008 |
MOLECULAR PHARMACOLOGY 4.0 (74.0), pp. 1152.0-1162.0 |
42 | 0 | 0 | 0 | 0 | 0 | 42 | |
| 10. | Albumin Effect on In Vitro Codeine (COD) Glucuronidation: Improving the Prediction of Hepatic Intrinsic Clearance | Pritsana Raungrut Benjamas Janchawee Verawan Uchaipichat David J. Elliot John O. Miners |
2009 |
DRUG METABOLISM REVIEWS (41.0), pp. 100.0-101.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 11. | Inhibition of codeine glucuronidation in vitro by fluconazole, ketamine, ketoconazole and valproic acid: Prediction of in vivo drug-drug interaction potential | John O. Miners Pritsana Raungrut Verawan Uchaipichat David J. Elliot Benjamas Janchawee |
2009 |
DRUG METABOLISM REVIEWS (41.0), pp. 76.0-76.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12. | Effects of Andrographis paniculata and Orthosiphon stamineus Extracts on the Glucuronidation of 4-Methylumbelliferone in Human UGT Isoforms | Sabariah Ismail Nur Aziah Hanapi Mohd Rohaimi Ab Halim Verawan Uchaipichat Peter I. Mackenzie |
2010 |
MOLECULES 5.0 (15.0), pp. 3578.0-3592.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 13. | Formulation Development of Morphine Sulfate Sustained-Release Tablets and Its Bioequivalence Study in Healthy Thai Volunteers | Detpon Preechagoon Viroj Sumyai Suvatna Chulavatnatol Poj Kulvanich Thanee Tessiri Khanittha Tontisirin Thaned Pongjanyakul Verawan Uchaipichat Sirikul Aumpon Chaiyasit Wongvipaporn |
2010 |
AAPS PHARMSCITECH 3.0 (11.0), pp. 1449.0-1455.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 14. | In Vitro-In Vivo Extrapolation Predicts Drug-Drug Interactions Arising from Inhibition of Codeine Glucuronidation by Dextropropoxyphene, Fluconazole, Ketoconazole, and Methadone in Humans | Pritsana Raungrut Verawan Uchaipichat David J. Elliot Benjamas Janchawee Andrew A. Somogyi John O. Miners |
2010 |
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 2.0 (334.0), pp. 609.0-618.0 |
91 | 0 | 0 | 0 | 0 | 0 | 91 | |
| 15. | Kinetic and Enzymatic Characterisation of Human Hepatic R- and S- Lorazepam Glucuronidation | Verawan Uchaipichat Chuthamanee Suthisisang Peter I. Mackenzie John O. Miners |
2010 |
DRUG METABOLISM REVIEWS (42.0), pp. 64.0-65.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 16. | The Albumin Effect on In vitro Kinetics of Various Cytochrome P450-Catalyzed Reactions: In vitro to In vivo Extrapolation | Nitsupa Wattanachai Wichittra Tassaneeyakul Verawan Uchaipichat John O. Miners |
2010 |
DRUG METABOLISM REVIEWS (42.0), pp. 77.0-78.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17. | Effects of Ketamine on Human UDP-Glucuronosyltransferases In Vitro Predict Potential Drug-Drug Interactions Arising from Ketamine Inhibition of Codeine and Morphine Glucuronidation | Verawan Uchaipichat Pritsana Raungrut Nuy Chau Benjamas Janchawee Allan M. Evans John O. Miners |
2011 |
DRUG METABOLISM AND DISPOSITION 8.0 (39.0), pp. 1324.0-1328.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
| 18. | In vitro approaches for the prediction of inhibition of drug glucuronidation clearance in humans | Verawan Uchaipichat Peter I. Mackenzie John O. Miners |
2011 |
DRUG METABOLISM REVIEWS (43.0), pp. 20.0-20.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 19. | In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6 alpha-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance | Nitsupa Wattanachai Thomas M. Polasek Tahlia M. Heath Verawan Uchaipichat Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul John O. Miners |
2011 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 8.0 (67.0), pp. 815.0-824.0 |
46 | 0 | 0 | 0 | 0 | 0 | 46 | |
| 20. | In vitro - in vivo extrapolation predicts a potential metabolic drug-drug interaction between ketamine and morphine | Verawan Uchaipichat Nuy Chau Pritsana Raungrut Benjamas Janchawee Peter Mackenzie John Miners |
2011 |
JOURNAL OF PHARMACOLOGICAL SCIENCES (115.0), pp. 285P-285P |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 21. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy | Narumol Jarernsiripornkul Piyanida Senacom Verawan Uchaipichat Nataporn Chaipichit Janet Krska |
2012 |
EPILEPSY & BEHAVIOR 1.0 (24.0), pp. 102.0-106.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 22. | The Glucuronidation of R- and S-Lorazepam: Human Liver Microsomal Kinetics, UDP-Glucuronosyltransferase Enzyme Selectivity, and Inhibition by Drugs | Verawan Uchaipichat Chuthamanee Suthisisang John O. Miners |
2013 |
DRUG METABOLISM AND DISPOSITION 6.0 (41.0), pp. 1273.0-1284.0 |
26 | 0 | 0 | 0 | 0 | 0 | 26 | |
| 23. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions | Nataporn Chaipichit Janet Krska Thongchai Pratipanawatr Verawan Uchaipichat Narumol Jarernsiripornkul |
2014 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 5.0 (70.0), pp. 607.0-615.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
| 24. | Experiences of adverse drug effects reported by patients in ambulatory clinic | Narumol Jarernsiripornkul Nataporn Chaipichit Janet Krska Verawan Uchaipichat Thongchai Pratipanawatr |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (37.0), pp. 213.0-213.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 25. | Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (37.0), pp. 224.0-225.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 26. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions | Narumol Jarernsiripornkul Nataporn Chaipichit Thongchai Pratipanawatr Verawan Uchaipichat Janet Krska |
2016 |
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 1.0 (25.0), pp. 54.0-63.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 27. | Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction | Methira Siriangkhawut Patthana Tansakul Verawan Uchaipichat |
2017 |
SAUDI PHARMACEUTICAL JOURNAL 6.0 (25.0), pp. 823.0-829.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 28. | In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans | Verawan Uchaipichat | 2018 |
DRUG METABOLISM AND PHARMACOKINETICS 1.0 (33.0), pp. 67.0-76.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 29. | IN VITRO INHIBITORY EFFECT OF TRICYCLIC ANTIDEPRESSANTS ON HUMAN LIVER MICROSOMAL MORPHINE GLUCURONIDATION | Verawan Uchaipichat Nantawat Thothumpol Nattaya Janpae |
2020 |
DRUG METABOLISM AND PHARMACOKINETICS 1.0 (35.0), pp. S48-S48 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Adverse Drug Reaction Monitoring to Antiepileptic Drugs by Patient Self Reports | Piyanida Senacom Narumol Jarernsiripornkul Verawan Uchaipichat |
2008 |
Srinagarind Medical Journal (23 No 4), pp. 373-382 |
|
| 2. | Development of a High Performance Liquid Chromatography with Coulometric Electrochemical Detector Method for the Analysis of Morphine in Human Plasma | Thanee Tessiri Viroj Sumyai Suvatana Chulavatnatol Poj Kulvanich Khanittha Tontisirin Thaned Pongjanyakul Sirikul Aumpon Verawan Uchaipichat Detpon Preechagoon |
2009 |
Isan Journal of Pharmaceutical Sciences (5 No 2), pp. 123-130 |
|
| 3. | Effect of Albumin on Human Cytochromes P450 Kinetics: Extrapolation of in Vivo Clearance from in Vitro Data | Nitsupa Wattanachai David J. Elliot Verawan Uchaipichat Wichittra Tassaneeyakul John O. Miners |
2010 |
Thai Journal of Pharmacology (32 No 1), pp. 246-249 |
|
| 4. | Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2014 |
Srinagarind Medical Journal (29 No 5), pp. 461-468 |
|
| 5. | Warfarin using knowledge and international normalized ratio goal control in outpatients of Queen Sirikit heart center of the northeast | Pattavee Loharattanakong Ploypilin Ritthiboon Yuwatida Hongrinya Maneepimai Chaichun Suthep Taksinachanekij Verawan Uchaipichat |
2016 |
Srinagarind Medical Journal (31 No 3), pp. 257-265 |
|
| 6. | Prevalence of Potential Statin-Drug Interactions in Dyslipidemic Patients at Srinagarind Hospital | Jantira Roddech Panadchanun Phiwbang Panjittra Kitirach Patcharin Nisanggad Pansu Sriangkan Chaiyasith Wongvipaporn Verawan Uchaipichat |
2016 |
Srinagarind Medical Journal (31 No 5), pp. 92-96 |
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ | ||
|---|---|---|---|---|---|---|
| 1. | การศึกษาผลของสารสำคัญในสมุนไพร ต่อการยับยั้งกระบวนการกลูคิวโรนิเดชันของยา มอร์ฟีนในหลอดทดลอง: การประยุกต์ใช้ข้อมูลการยับยั้งเอนไซม์ในหลอดทดลองเพื่อคาดการณ์การ เกิดอันตรกิริยาที่กระบวนการเมแทบอลิซึมระหว่างยามอร์ฟีนและสมุนไพรในมนุษย์ |
ผศ.ดร. วีรวรรณ อุชายภิชาติ |
โครงการ | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 2. | การประยุกต์ใช้ข้อมูลการยับยั้งเอนไซม์ในหลอดทดลองเพื่อคาดการณ์ระดับการเกิดอันตรกิริยาระหว่างยาที่เกิดจากการยับยั้งกระบวนการกลูคิวโรนิเดชันของยามอร์ฟีนโดยยาต้านการอักเสบที่ไม่ใช่สเตียรอยด์ในมนุษย์ |
ผศ.ดร. วีรวรรณ อุชายภิชาติ |
โครงการ | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 3. | รูปแบบการศึกษาผลการยับยั้งกระบวนการกลูคูโรนิเดชันของยาอะเซตามีโนเฟนในหลอดทดลอง ซึ่งสามารถนำไปใช้คัดกรองโอกาสในการเกิดอันตรกิริยาเมื่อได้รับยาอะเซตามีโนเฟนร่วมกับยาอื่นหรือสารสำคัญในสมุนไพร |
ผศ.ดร. วีรวรรณ อุชายภิชาติ |
โครงการ | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) |